- Home
- UNH vs ABT Comparison
UNH vs ABT Comparison
Compare UNH & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- ABT
- Stock Information
- Founded
- UNH 1977
- ABT 1888
- Country
- UNH United States
- ABT United States
- Employees
- UNH N/A
- ABT N/A
- Industry
- UNH Medical Specialities
- ABT Medical/Dental Instruments
- Sector
- UNH Health Care
- ABT Health Care
- Exchange
- UNH Nasdaq
- ABT Nasdaq
- Market Cap
- UNH 279.9B
- ABT 233.7B
- IPO Year
- UNH 1984
- ABT N/A
- Fundamental
- Price
- UNH $308.49
- ABT $130.27
- Analyst Decision
- UNH Buy
- ABT Strong Buy
- Analyst Count
- UNH 24
- ABT 19
- Target Price
- UNH $399.91
- ABT $142.79
- AVG Volume (30 Days)
- UNH 23.4M
- ABT 6.0M
- Earning Date
- UNH 10-14-2025
- ABT 10-15-2025
- Dividend Yield
- UNH 2.87%
- ABT 1.81%
- EPS Growth
- UNH 52.72
- ABT 151.50
- EPS
- UNH 23.12
- ABT 7.97
- Revenue
- UNH $422,818,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- UNH $13.33
- ABT $7.60
- Revenue Next Year
- UNH $6.23
- ABT $7.84
- P/E Ratio
- UNH $13.35
- ABT $16.34
- Revenue Growth
- UNH 9.70
- ABT 5.85
- 52 Week Low
- UNH $234.60
- ABT $110.33
- 52 Week High
- UNH $630.73
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- UNH 65.66
- ABT 50.36
- Support Level
- UNH $239.50
- ABT $128.33
- Resistance Level
- UNH $253.16
- ABT $132.35
- Average True Range (ATR)
- UNH 9.74
- ABT 2.55
- MACD
- UNH 7.68
- ABT 0.30
- Stochastic Oscillator
- UNH 90.33
- ABT 51.95
About UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.